Table 1.
Demographic and clinical characteristics of leprosy patients
| A - Characteristics of the samplea | ||||
| N individuals | Age, years ± SD |
Gender M:F | ||
| Cases / Reaction | 94 | 44.05 (13.31) | 58:36 | |
| Controls / No Reaction | 57 | 45.21 (14.98) | 28:29 | |
| B - Clinical characteristics of the cohorta | ||||
| Clinical phenotype | n | (%) | ||
| Tuberculoid (TT) | 20 | (13) | ||
| Borderline tuberculoid (BT) | 30 | (20) | ||
| Borderline (BB) | 18 | (12) | ||
| Borderline lepromatous (BL) | 17 | (11) | ||
| Lepromatous (LL) | 49 | (32) | ||
| Indeterminate leprosy (I) | 11 | (7) | ||
| Other forms (Neural) | 6 | (4) | ||
| Total# | 151 | (100) | ||
| C - Patients with reaction episodea | ||||
| RR | 50 | (53) | ||
| ENL | 44 | (47) | ||
| Total# | 94 | (62) | ||
| D - Patients without reaction episodea | ||||
| PB | 47 | (82) | ||
| MB | 10 | (18) | ||
| Total# | 57 | (38) | ||
aResults are shown as N(%). Abbreviations: SD Standart deviation, M male, F female, PB paucibacillary, MB multibacillary, RR reversal reaction, ENL erythema nodosum leprosum. Patients were also classified under leprosy clinical spectrum according to Ridley & Jopling [9]